UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002856 |
|---|---|
| Receipt number | R000003443 |
| Scientific Title | Phase I/II study of VEGFR1/2-derived peptide vaccination in combination with a 5-fluorouracil derivative (TS-1) for metastatic colorectal cancer with KRAS genetic mutation as a third-line therapy |
| Date of disclosure of the study information | 2010/01/01 |
| Last modified on | 2012/06/08 09:21:02 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/12/07 19:16:42 | ||
| 2 | Update | 2010/12/08 13:24:35 | Recruitment status |
|
| 3 | Update | 2011/12/08 15:28:54 | Recruitment status Last follow-up date Date of closure to data entry |
|
| 4 | Update | 2012/06/08 09:19:06 | Recruitment status |
|
| 5 | Update | 2012/06/08 09:21:02 | Name of person sending information Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
